NeuPath Health Revenue Growth Remains Strong at 26% in Q3 2021


  • Total medical services revenue increased by 26% to $15.2 million in the quarter
  • Same-clinic revenue growth of 14% YTD through September 30, 2021
  • 11th consecutive quarter of positive adjusted EBITDA
  • Expanded technology offering by closing acquisition of KumoCare and forming partnership with Cynergi Health Partners

 TORONTO, ONTARIO, November 12, 2021 – NeuPath Health Inc. (TSXV:NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics delivering category-leading chronic pain treatment, today announced its financial and operating results for the three and nine months ended September 30, 2021. All figures are in Canadian dollars, unless otherwise noted.

Continue in PDF